ArticleFrontiers in neurology2025

Neurological adverse events of ROS1 inhibitors for non-small cell lung cancer: data from the FDA adverse event reporting system.

Xueying Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.